What We Offer

Our services are designed to accelerate your cancer research and drug development.

1. Preclinical Pharmacology Studies (PD/PK, Acute Toxicology)

Used to optimize dosing regimens and administration routes during drug development, assess safety profiles, and provide pharmacological data to support both preclinical research and academic studies.

2. Dual Humanized Tumor and Immune System Xenograft Tumor Models Study

Primarily applied in the study of tumor-immune interactions and the development and evaluation of immunotherapies, offering higher clinical relevance for preclinical testing.

3. Advanced Imaging & Tumor Visualization Models Study

Enable real-time, non-invasive monitoring of tumor growth and treatment response in orthotopic tumor models, enhancing the efficiency and accuracy of in vivo drug efficacy assessments.

4. Metastatic Cancer Mouse Models Study

Designed to explore the mechanisms of cancer metastasis and provide foundational models for the development and evaluation of anti-metastatic therapies.

5. Personalized Precision Cancer Treatment Studies

Support the development of personalized cancer treatment strategies based on individual tumor characteristics, and facilitate research on tumor heterogeneity and drug resistance.

6. EchoMRI-Based Metabolic Disease Research

The EchoMRI system offers rapid, repeatable, and anesthesia-free measurements of fat mass, lean mass, and body water in small animals. As a globally recognized tool in metabolic phenotyping, it plays a crucial role in evaluating the progression of metabolic disorders and the efficacy of therapeutic interventions.

What Our Clients Say

Interested in our services?

Contact us to discuss how we can support your research needs.